 For NPR News, I'm Jeff London. For only the second time, U.S. health officials are approving a new Alzheimer's drug that has shown a modest ability to slow the memory-destroying disease. The Food and Drug Administration approving the medicine made by Eli Lilly for patients with early or mild cases of dementia due to Alzheimer's. A drug called Kinsonla is not a cure, but is said to slow worsening memory and cognitive problems by around seven months.